The mesolimbic dopamine system as a target for rapid antidepressant action

International Clinical Psychopharmacology

Volumn 12, Issue SUPPL.3, 1997, Pages

  Willner, Paul ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Animal models of depression; Antidepressant drugs; Chronic mild stress; Dopamine; Rapid onset

Indexed keywords

AMINEPTINE; AMISULPRIDE; ANTIDEPRESSANT AGENT; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR; PRAMIPEXOLE; ROXINDOLE; SULPIRIDE; TOLCAPONE;

ANIMAL MODEL; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG SCREENING; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0030867369     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199707003-00002     Document Type: Review

References (68)

1. Alfredsson G, Sedvall G (1985) Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients: relationship to drug concentrations. Psychopharmacology 85:8-13.
2. Ammar S, Martin P (1991) Modelling the effects of dopamine agonists in psychopharmacology: towards a clinical and experimental thesis [in French]. Psychol Française 36:221-232.
3. Ayd FJ Jr, Zohar J (1987) Psychostimulant (amphetamine or methylphenidate) therapy for chronic and treatment-resistant depression. In: Treating Resistant Depression. Edited by Zohar J, Belmaker RH. New York: PMA Corporation; pp 343-355.
4. Benkert O, Brunder G, Wetzel H (1992) Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Pharmacopsychiatry 25:254-260.
5. Blier P, De Montigny C, Chaput Y (1990) A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 51 (suppl):14-20,21.
6. Borsini F, Meli A (1990) The forced swimming test: its contribution to the understanding of the mechanisms of action of antidepressants. In: Dopamine and Mental Depression. Edited by Gessa GL, Serra G. Oxford: Pergamon Press; pp 63-76.
7. Brown AS, Gershon S (1993) Dopamine and depression. J Neural Transm Gen Sect 91:75-109.
8. Bocchetta A, Bernardi F, Burrai C, Pedditzi M, Del Zompo M (1993) A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives. Acta Psychiatr Scand 88:434-439.
9. Boyer P, Lecrubier Y, Puech AJ, Laferriere N, Fleurot O (1992) Treatment of dysthymia with low-dose amisulpride versus amineptine. Clin Neuropharmacol 15 (suppl 1):524B.
10. Boyer P, Lecrubier Y, Puech AJ, Dewailly J, Aubin F (1995) Treatment of negative symptoms in schizophrenia with amisulpride. Br J Psychiatr 156:68-72.
11. Bruynooghe F, Geerts S, Van Maele G, Vogtle Jungert U (1992) Treating resistant depression with sulpiride: double-blind comparative studies with sulpiride and amitriptyline [in German]. Fortschr Med 110:62-68.
12. Cador M, Robbins TW, Everitt BE, Simon H, Le Moal M, Stimus L (1991) Limbic-striatal interactions in reward processes: modulation by the dopaminergic system. In: The Mesolimbic Dopamine System: From Motivation to Action. Edited by Willner P, Scheel-Kruger J. New York: Wiley; pp 225-250.
13. Carboni E, Tanda GL, Frau R, Di Chiara G (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1070.
14. Cervo L, Samanin R (1988) Repeated treatment with imipramine and amitriptyline reduces the immnobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens. J Pharm Pharmacol 40:155-156.
15. Cervo L, Grignaschi G, Samanin R (1990) The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test. Eur J Pharmacol 178:129-133.
16. Cheeta S, Broekkamp C, Willner P (1994) Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer. Psychopharmacology 116:523-528.
17. D'Aquila P, Brain PF, Willner P (1994) Effects of chronic mild stress in behavioural tests relevant to anxiety and depression. Physiol Behav 56:861-867.
18. Delina-Stula A, Radeke E, van Riezen H (1988) Enhanced functional responsiveness of the dopaminergic system: the mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the rat. Neuropharmacology 27:943-947.
19. Del Zompo M, Bocchetta A, Bernardi F, Burrai C, Corsini GU (1990) Clinical evidence for a role of dopaminergic system in depressive syndromes. In: Dopamine and Mental Depression. Edited by Gessa GL, Serra G. Oxford: Pergamon Press; pp 177-184.
20. De Montigny C, Chaput Y, Blier P (1990) Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 51 (suppl):4-8.
21. De Montis MG, Devoto P, Gessa GL, Porcella A, Serra G, Tagliamonte A (1990) Possible role of DA receptors in the mechanism of action of antidepressants. In: Dopamine and Mental Depression. Edited by Gessa GL, Serra G. Oxford: Pergamon Press; pp 147-157.
22. De Montis MG, Gambarana C, Meloni D, Taddei I, Tagliamonte A (1993) Long-term imipramine effects are prevented by NMDA receptor blockade. Brain Res 606:63-67.
23. Groenewegen HJ, Berendse HW, Meredith GE, et al. (1991) Functional anatomy of the ventral, limbic system-innervated striatum. In: The Mesolimbic Dopamine System: From Motivation to Action. Edited by Willner P, Scheel-Kruger J. New York: Wiley; pp 19-59.
24. 3H-spiperone to dopaminergic receptors. In: Dopamine and Mental Depression. Edited by Gessa Gl, Serra G. Oxford: Pergamon Press; pp 159-166.
25. Lecrubier Y, Boyer P, Puech AJ, Aubin F, Rein W (1992) Amisulpride versus imipramine and placebo in dysthymia [abstract]. Clin Neuropharmacol 15 (suppl 1):526B.
26. Maj J (1990) Behavioral effects of antidepressant drugs given repeatedly on the dopaminergic system. In: Dopamine and Mental Depression. Edited by Gessa GL, Serra G. Oxford: Pergamon Press; pp 139-146.
27. Maj J, Papp M, Skuza G, Bigajska K, Zazula M (1989) The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists. J Neural Transm 76:29-38.
28. Martin-Iverson M, Leclere JF, Fibiger HC (1983) Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants. Eur J Pharmacol 94:193-201.
29. Mierau J (1995) Pramipexole: a dopamine-receptor agonist for treatment of Parkinson's disease. Clin Neuropharmacol 18 (suppl 1): S195-S206.
30. 2 receptor agonist. Eur J Pharmacol 215:161-170.
31. Moreau J-L, Borgulya J, Jenck F, Martin JR (1994) Tolcapone: a potential new antidepressant detected in a novel animal model of depression. Behav Pharmacol 5:344-351.
32. Moreau J-L, Scherschlicht R, Jenck F, Martin JR (1995) Chronic mild stress-induced anhedonia model of depression: sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol 6:682-687.
33. Mouret J, Lemoine P, Minuit M-P (1987) Polygraphie, clinical and therapeutic markers of dopamine-dependent depression [in French]. C R Acad Sci III 305:301-306.
34. Muscat R, Papp M, Willner P (1992) Antidepressant-like actions of dopamine agonists in an animal model of depression. Biol Psychiatry 31:937-946.
35. Nielsen EB, Andersen PH (1990) GBR 12909: a new potent and selective dopamine uptake inhibitor. In: Dopamine and Mental Depression. Edited by Gessa GL, Serra G. Oxford: Pergamon Press; pp 101-108.
36. Nelson JC (1987) The use of antipsychotic drugs in the treatment of depression. In: Treating Resistant Depression. Edited by Zohar J, Belmaker RH. New York: PMA Corporation; pp 131-146.
37. 1) receptors is species-specific. Pharmacol Biochem Behav 39:769-771.
38. Paillère-Martinot M-L, Lecrubier Y, Martinot J-L, Aubin F (1994) Improvement of some schizophrenic deficit symptoms with low doses of amisulpride. Am J Psychiatry 152:130-133.
39. Papp M, Muscat R, Willner P (1993) Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress. Psychopharmacology 110:152-158.
40. 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 115:441-446.
41. Papp M, Moryl E, Willner P (1996) Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol 296: 129-136.
42. Paul IA, Nowak G, Layer RT, Popok P, Skolnick P (1994) Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 269:95-102.
43. Petit M, Zahn M, Colonna L (1984) Controlled study of the disinhibiting effect of weak doses of sulpiride in deficit schizophrenic psychosis [in French]. Encephale 10:557-559.
44. Post RM, Gerner RH, Carman JS, et al. (1978) Effects of a dopamine agonist piribedil in depressed patients. Arch Gen Psychiatry 35:609-615.
45. Przegalinski E, Budziszewska B, Blaszcztnska E (1990) Repeated treatment with antidepressant drugs and/or electroconvulsive shock (ECS) does not affect the quinpirole-induced elevation of serum corticosterone concentration in rats. J Psychopharmacol 4:198-203.
46. Pulverenti L, Samanin R (1986) Antagonism by dopamine, but not noradrenaline receptor blockers of the anti-immobility activity of desipramine after different treatment schedules in the rat. Pharmacol Res Commun 18:73-80.
47. Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology 53:309-314.
48. Rampello L, Nicoletti G, Raffaele R (1991) Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatr Scand 84:552-554.
49. Reus VI, Lake CR, Post RM (1980) Effect of piribedil (ET-495) on plasma norepinephrine: relationship to antidepressant response. Commun Psychopharmacol 4:207-213.
50. Robertson MM, Trimble MR (1981) Neuroleptics as antidepressants. Neuropharmacology 20:1335-1336.
51. 2 receptors. Neuroreport 6:329-332.
52. Satel SL, Nelson JC (1988) Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry 50:241-249.
53. Scatton B, Worms P, Zivcovic B, Deportere H, Dedek J, Bartholini G (1979) On the neuropharmacological spectra of 'classical' (haloperidol) and 'atypical' (benzamide derivatives) neuroleptics. In: Sulpiride and Other Benzamides. Edited by Spano PF, Trabucchi M, Corsini GU, Gess GL. New York: Raven Press; pp 53-56.
54. 3 receptors [abstract]. Neuropsychopharmacology 10 (suppl part 1):242S.
55. Serra G, Argiolas A, Fadda F, Melis MR, Gessa GL (1979) Chronic treatment with antidepressants prevents the inhibitory effect of small doses of antidepressants on dopamine synthesis and motor activity. Life Sci 25:415-424.
56. Serra G, Van Ree JM, De Wied D (1983) Influence of classical and atypical neuroleptics on apomorphine induced behavioural changes and on extinction of a conditioned avoidance response. J Pharm Pharmacol 35:255-257.
57. Serra G, Forgione A, D'Aquila PS, Collu M, Fratta W, Gessa GL (1990) Blockade of DA autoreceptors: possible mechanism of antidepressant action of L-sulpiride. In: Dopamine and Mental Depression. Edited by Gessa GL, Serra G. Oxford: Pergamon Press; pp 185-191.
58. Shopsin B, Gershon S (1978) Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495). Neuropsychobiology 4:1-14.
59. Silverstone T (1984) Response to bromocriptine distinguishes bipolar from unipolar depression. Lancet i:903-904.
60. Theohar C, Fischer-Cornellson K, Akesson HO, et al. (1981) Bromocriptine as antidepressant: double-blind comparative study with imipramine in psychogenic and endogenous depression. Curr Ther Res 30:830-842.
61. Towell A, Willner P, Muscat R (1986) Behavioural evidence for autoreceptor subsensitivity in the mesolimbic dopamine system during withdrawal from antidepressant drugs. Psychopharmacology 90:64-71.
62. Waehrens J, Gerlach J (1981) Bromocriptine and imipramine in endogenous depression: a double-blind controlled trial in out-patients. J Affect Disord 3:193-202.
63. Willner P (1985) Depression: A Psychobiological Synthesis. New York: Wiley.
64. Willner P (1989) Sensitization to antidepressant drugs. In: Psychoactive drugs: Tolerance and Sensitization. Edited by Emmett-Oglesby MW, Goudie AJ. Clifton, New Jersey: Humana Press; pp 407-459.
65. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology 93:358-364.
66. Willner P, Muscat R, Papp M (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525-534.
67. Willner P, Lappas S, Cheeta S, Muscat R (1994) Reversal of stress-induced anhedonia by the dopamine agonist, pramipexole. Psychopharmacology 115:454-462
68. Zebrowska-Lupina I, Ossowska G, Klenk-Majewska B (1992) The influence of antidepressants on aggressive behavior in stressed rats: the role of dopamine. Pol J Pharmacol Pharm 44:325-335.